Articles
Sawyer
Woman Continues Battle
By Patrick Springer
The Forum - 02/26/2006
Cheree Schneider is two months into a drug regimen her doctor
hopes will tame the inflammation that is deteriorating her muscles
and keeps her confined to a chair most of the day.
Although the Sawyer, N.D., woman hopes the therapy
will work, she and her mother also are working to raise money
to help her travel to Chicago for a stem-cell transplant,
if her doctors prescribe the treatment.
Schneider is battling mixed connective tissue
disease, a complex autoimmune illness combining symptoms of
systemic Lupus and scleroderma. Lupus is a chronic inflammation
of the skin and organs; scleroderma thickens and hardens skin
and organs.
Doctors have been unable to halt progression
of the disease, which was diagnosed in fall 2003, just as
she was about to graduate from a cosmetology school in Minot,
N.D., at age 28.
Since then, Schneider’s condition has
declined markedly. Last fall, she had to stop treatments of
Rituximab, a drug originally used to treat cancer, because
she couldn’t tolerate the side effects.
Now she is on another drug, cyclosporine, but
it is too early to determine whether the treatment will help.
Dr. James Carpenter, a rheumatologist at Fargo’s
MeritCare, said it generally takes about four months to determine
whether the drug is effective. Schneider has at least two
more months of waiting.
If cyclosporine doesn’t provide relief,
her next hope would be an expensive treatment to harvest her
own stem cells.
“I’m still trying to raise money
for the stem-cell,” Schneider said. “Nobody has
canceled that idea.”
Last year, Schneider traveled to Chicago, where
specialists at Northwestern Memorial Hospital determined she
was a candidate for a stem-cell transplant.
Last fall, North Dakota Medicaid officials offered
reimbursement for the procedure – which normally costs
$150,000 for hospital coverage alone – that was $21,000
short of what the medical center could accept as a minimum
payment.
Maggie Anderson, the official who oversees Medicaid
in North Dakota, said recently that the state still is trying
to work out a payment agreement with Northwestern if doctors
recommend a stem-cell transplant treatment.
Still, Schneider said Northwestern has informed
her they still haven’t come to terms with North Dakota
Medicaid. The nurse asked her how her fundraising efforts
were going.
Benefits in Minot raised $1,800 last year, she
said. Much of that money was spent traveling to Chicago for
the evaluation.
“I’ve been researching everywhere
for how to get funds, how to get support,” she said.
“It’s an ongoing battle to raise money.”
With help from her mother, also her primary
caregiver, the Lion’s Club in Sawyer, N.D., held a pancake-and-sausage
benefit feed last month, raising $600. Supporters now are
trying to organize a lutefisk feed to raise more money.
If she requires a transplant, Schneider would
have to stay in downtown Chicago, no more than four blocks
from the medical center, for four to six months. Rents in
that neighborhood, she said, run $3,000 a month for a one-bedroom
apartment.
Meanwhile, Schneider will continue to take her
cyclosporine in the hope she’ll show positive results.
The drug can cause high-blood pressure and kidney damage
Readers can reach Forum reporter Patrick Springer at (701)
241-5522
<<BACK
|